Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baricitinib in Acute Alopecia Areata
NCT06797310Phase 2Not yet recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Jan 2025
- Primary completion
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of baricitinib in alopecia areata, sponsored by National Taiwan University Hospital. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
baricitinib
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT06797310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06797310.